Autor: |
Jansen RW; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., de Bloeme CM; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Cardoen L; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Göricke S; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., van Elst S; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Jessen JL; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Ramasubramanian A; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Skalet AH; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Miller AK; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Maeder P; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Uner OE; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Hubbard GB; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Grossniklaus H; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Boldt HC; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Nichols KE; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Brennan RC; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Sen S; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Sirin S; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Brisse HJ; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Galluzzi P; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Dommering CJ; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Castelijns JA; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., van der Valk P; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Boellaard R; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Dorsman J; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., Moll AC; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., de Jong MC; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.)., de Graaf P; From the Departments of Radiology and Nuclear Medicine (R.W.J., C.M.d.B., S.v.E., J.A.C., R.B., M.C.d.J., P.d.G.), Human Genetics (C.J.D.), Pathology (P.v.d.V.), Oncogenetics (J.D.), and Ophthalmology (A.C.M.), Amsterdam University Medical Center, Vrije Universiteit, Office PK-1X012, De Boelelaan 1117, 1081 HV Amsterdam, the Netherlands; Cancer Center Amsterdam, Amsterdam, the Netherlands (R.W.J., C.M.d.B., S.v.E., J.D., A.C.M., M.C.d.J., P.d.G.); European Retinoblastoma Imaging Collaboration (R.W.J., C.M.d.B., L.C., S.G., P.M., H.C.B., P.G., J.A.C., M.C.d.J., P.d.G.); Imaging Department, Institut Curie Paris, Paris, France (L.C., H.J.B.); Institute of Diagnostic and Interventional Radiology and Neuroradiology, University Hospital Essen, Essen, Germany (S.G.); Impact Genetics-Dynacare, Brampton, Canada (J.L.J.); Department of Ophthalmology, Phoenix Children's Hospital, Phoenix, Ariz (A.R.); Casey Eye Institute & Knight Cancer Institute, Oregon Health & Science University, Portland, Ore (A.H.S., A.K.M.); Department of Radiology, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland (P.M.); Department of Ophthalmology, Casey Eye Institute, Oregon Health & Science University, Portland, Ore (O.E.U.); Ocular Oncology Service, Emory Eye Center, Atlanta, Ga (O.E.U., G.B.H., H.G.); Department of Ophthalmology, University of Iowa Hospitals & Clinics, Iowa City, Iowa (H.C.B.); Department of Oncology, St Jude Children's Research Hospital, Memphis, Tenn (K.E.N., R.C.B.); Department of Pediatric Hematology/Oncology, Logan Health, Kalispell, Mont (R.C.B.); Department of Radiology and Imaging Sciences, Tata Medical Center, Kolkata, India (S. Sen); Department of Diagnostic Imaging, University Children's Hospital Zürich, Zürich, Switzerland (S. Sirin); and Azienda Ospedaliera Universitaria Senese, Siena, Italy (P.G.). |